Peptide Partners
9 tests · avg lab score 5.8/10
Latest Finnrick test Oct 20, 2025
Research
CJC-1295
Growth hormone releasing hormone analog with extended half-life.
Grade
C
Finnrick lab signal
Lowest
$34.50Lowest
Polaris PeptidesTrust
100trust
← Back to peptide comparison
Price comparison
Source: Vendor websitesLast tested Mar 2026Current offers across tracked vendors
Lowest price first, with Finnrick grades in the same row so cost never gets divorced from lab context.
Lab data
What the Finnrick results actually show
We highlight current purity and quantity results without implying every vendor or every batch has been tested equally.
Purity distribution
No Finnrick test results are attached to this peptide yet.
C
Price history
Historical tracking comes next
The current schema gives us a trustworthy live market snapshot. It does not yet store price snapshots over time, so the chart module stays honest about that gap.
Historical pricing
Tracking starts with snapshots
The current schema stores live prices but not historical snapshots yet, so this page shows current market comparison rather than pretending time-series data exists. Once snapshots are recorded, this module can render 30-, 90-, and 180-day trends honestly.
Research context
Editorial context beyond the price table
The goal is to keep market data inside a broader research and safety frame, not let the price table become the whole story.
Guide
CJC-1295 explainer
CJC-1295 is a GHRH analog that stimulates pituitary GH release. Limited human clinical data exists; it is not FDA-approved and is classified as a compounding safety concern.
Read the full research guide →Coverage
No related headlines yet
This compound hasn't been tagged in the news feed yet. When new coverage lands, we'll surface it here instead of stuffing the section with irrelevant filler.
Research information only
Peptide Daily is an informational resource only. Peptide research chemicals are not approved for human use by the FDA unless otherwise noted. Nothing on this site constitutes medical advice. Consult a qualified healthcare provider before using any peptide or research chemical.